Feasibility of cabazitaxel in octogenarian prostate cancer patients

BACKGROUND: To evaluate the effectiveness and safety of cabazitaxel in castration-resistant prostate cancer patients aged ≥80 years, we performed a retrospective study on a sample of patients from 11 Italian cancer centers. MATERIALS AND METHODS: Fifty-seven patients aged ≥80 years were treated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Tralongo, Paolo, Bordonaro, Sebastiano, Di Lorenzo, Giuseppe, De Giorgi, Ugo, Borsellino, Nicolò, Facchini, Gaetano, Rossetti, Sabrina, Fornarini, Giuseppe, Longo, Vito, Tralongo, Antonino Carmelo, Caspani, Francesca, Spada, Massimiliano, Calvani, Nicola, Carlini, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Special Topic - Advances in Prostate Cancer Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337820/
https://www.ncbi.nlm.nih.gov/pubmed/37448615
http://dx.doi.org/10.1097/CU9.0000000000000081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337820/
https://www.ncbi.nlm.nih.gov/pubmed/37448615
http://dx.doi.org/10.1097/CU9.0000000000000081

Ejemplares similares